Oral administration of Lactococcus lactis expressing Helicobacter pylori Cag7-ct383 protein induces systemic anti-Cag7 immune response in mice

FEMS Immunology and Medical Microbiology

Volumn 57, Issue 3, 2009, Pages 257-268

  Kim, Su Jung ^a,b   Lee, Ji Young ^a   Jun, Do Youn ^a   Song, Jae Young ^c   Lee, Woo Kon ^c   Cho, Myung Je ^c   Kim, Young Ho ^a  

^a Kyungpook National University   (South Korea)

^b Daegu Health College   (South Korea)

^c Gyeongsang National University School of Medicine   (South Korea)

Author keywords

Helicobacter pylori Cag7; Mucosal and systemic immunity; Oral vaccine; Recombinant Lactococcus lactis

Indexed keywords

AMINO ACID; ANTIBODY; BACTERIAL PROTEIN; CAG7 ANTIBODY; CAG7 CT383 PROTEIN; FREUND ADJUVANT; GST CAG7 CT383 FUSION PROTEIN; HYBRID PROTEIN; PROTEIN CAG7; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; BIOTRANSFORMATION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ESCHERICHIA COLI; EXTRACELLULAR MATRIX; GENE EXPRESSION; HELICOBACTER PYLORI; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; LACTOCOCCUS LACTIS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; SERUM; SHUTTLE VECTOR; WESTERN BLOTTING;

ADMINISTRATION, ORAL; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; DNA, BACTERIAL; GENETIC VECTORS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; LACTOCOCCUS LACTIS; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; VACCINES, SYNTHETIC;

EID: 71049167149     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2009.00605.x     Document Type: Article

References (37)

1. Alm RA, Ling LS, Moir DT et al 1999) Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397 : 176 180.
2. Backert S Selbach M (2008) Role of type IV secretion in Helicobacter pylori pathogenesis. Cell Microbiol 10 : 1573 1581.
3. Bermudez-Humaran LG, Langella P, Miyoshi A, Gruss A, Guerra RT, Montes de Oca-Luna R Le Loir Y (2002) Production of human papillomavirus type 16 E7 protein in Lactococcus lactis. Appl Environ Microb 68 : 917 922.
4. Berzofsky JA (1988) Features of T-cell recognition and antigen structure useful in the design of vaccines to elicit T-cell immunity. Vaccine 6 : 89 93.
5. Berzofsky JA, Cease KB, Cornette JL, Spouge JL, Margalit H, Berkower IJ, Good MF, Miller LH DeLisi C (1987) Protein antigenic structures recognized by T cells: potential applications to vaccine design. Immunol Rev 98 : 9 52.
6. Chen M, Chen J, Liao W, Zhu S, Yu J, Leung WK, Hu P Sung JJ (2003) Immunization with attenuated Salmonella typhimurium producing catalase in protection against gastric Helicobacter pylori infection in mice. Helicobacter 8 : 613 625.
7. Cheun HI, Kawamoto K, Hiramatsu M, Tamaoki H, Shirahata T, Igimi S Makino SI (2004) Protective immunity of SpaA-antigen producing Lactococcus lactis against Erysipelothrix rhusiopathiae infection. J Appl Microbiol 96 : 1347 1353.
8. Crespo A Suh B (2001) Helicobacter pylori infection: epidemiology, pathophysiology, and therapy. Arch Pharm Res 24 : 485 498.
9. Czinn SJ (2004) Helicobacter infection: pathogenesis. Curr Opin Gastroenterol 20 : 10 15.
10. Dong XN, Qi Y, Ying J, Chen X Kim YH (2006) Candidate peptide vaccine induced potent protection against CSFV and identified a principal sequential neutralizing determinant on E2. Vaccine 24 : 426 434.
11. Holo H Nes IF (1989) High-frequency transformation by electroporation of Lactococcus lactis subsp. cemoris grown with glycine in osmotically stabilized media. Appl Environ Microb 55 : 3119 3123.
12. Jun DY, Rue SW, Kim BW Kim YH (2003) Detection of mitotic centromere-associated kinesin (MCAK) during cell cycle progression of human Jurkat T cells using polyclonal antibody raised against its N-terminal region overexpressed in E. coli. J Microbiol Biotechn 13 : 912 918.
13. Khan AA, Babu JP, Gupta G Rao DN (2008) Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune response of V antigen of Yersinia pestis. Vaccine 26 : 316 332.
14. Kim SJ, Jun DY, Yang CA Kim YH (2006a) Cloning and expression of hpaA gene of Korean strain Helicobacter pylori 51 in oral vaccine delivery vehicle Lactococcus lactis subsp. lactis MG1363. J Microbiol Biotechn 16 : 318 324.
15. Kim SJ, Jun DY, Yang CH Kim YH (2006b) Expression of Helicobacter pylori cag12 gene in Lactococcus lactis MG1363 and its oral administration to induce systemic anti-Cag12 immune response in mice. Appl Microbiol Biot 72 : 462 470.
16. Kitazawa H, Itoh T, Tomioka Y, Mizugaki M Yamaguchi T (1996) Induction of IFN-gamma and IL-1 alpha production in macrophages stimulated with phosphopolysaccharide produced by Lactococcus lactis ssp. cremoris. Int J Food Microbiol 31 : 99 106.
17. Kyte J Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157 : 105 132.
18. Lee MH, Roussel Y, Wiks M Tabaqchali S (2001) Expression Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice. Vaccine 19 : 3927 3935.
19. Lee WK, Choi SH, Park SG et al 1999) Genomic diversity of Helicobacter pylori. J Korean Soc Microbiol 34 : 519 532.
20. Liu XL, Li SQ, Liu CJ, Tao HX Zhang ZS (2004) Antigen epitope of Helicobacter pylori vacuolating cytotoxin A. World J Gastroentero 10 : 2340 2343.
21. Llosa M O'Callaghan D (2004) Euroconference on the biology of type IV secretion processes: bacterial gates into the outer world. Mol Microbiol 53 : 1 8.
22. Nouaille S, Ribeiro LA, Miyoshi A, Pontes D, Le Loir Y, Oliverira SC, Langella P Azevedo V (2003) Heterologous protein production and delivery systems for Lactococcus lactis. Genet Mol Res 2 : 102 111.
23. Pei H, Liu J, Cheng Y, Sun C, Wang C, Lu Y, Ding J, Zhou J Xiang H (2005) Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination. Appl Microbiol Biot 68 : 220 227.
24. Prinz C, Hafsi N Voland P (2003) Helicobacter pylori virulence factors and the host immune response: implications for therapeutic vaccination. Trends Microbiol 11 : 134 138.
25. Ribeiro LA, Azevedo V, Le Loir Y, Oliveira SC, Dieye Y, Piard JC, Gruss A Langella P (2002) Production and targeting of the Brucella abortus antigen L7L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosis. Appl Environ Microb 68 : 910 916. (Pubitemid 34113084)
26. Robinson K, Chamberlain LM, Lopez MC, Rush CM, Marcotte H, Le Page RW Wells JM (2004) Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C. Infect Immun 72 : 2753 2761.
27. Rohde M, Puls J, Buhrdorf R, Fischer W Haas R (2003) A novel sheathed surface organelle of the Helicobacter pylori cag type IV secretion system. Mol Microbiol 49 : 219 234.
28. Satin B, Del Giudice G, Della Bianca V, Dusi S, Laudanna C, Tonello F, Kelleher D, Rappuoli R, Montecucco C Rossi F (2000) The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med 191 : 1467 1476.
29. Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W Remaut E (2000) Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289 : 1352 1355.
30. Tai SS, Wang TR Lee CJ (1997) Characterization of hemin binding activity of Streptococcus pneumoniae. Infect Immun 65 : 1083 1087.
31. Tanaka J, Suzuki T, Mimuro H Sasakawa C (2003) Structural definition on the surface of Helicobacter pylori type IV secretion apparatus. Cell Microbiol 5 : 395 404.
32. Theisen M, Soe S, Brunstedt K, Follmann F, Bredmose L, Israelsen H, Madsen SM Druilhe P (2004) A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies. Vaccine 22 : 1188 1198.
33. Tomb JF, White O, Kerlavage AR et al 1997) The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388 : 539 547.
34. Van De Guchte M, Jos M, Der Vossen BM, Kok J Venema G (1989) Construction of a Lactococcal expression vector: expression of hen egg white lysozyme in Lactococcus lactis subsp. lactis. Appl Environ Microb 55 : 224 228.
35. Xin KQ, Hoshino Y, Toda Y et al 2003) Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env. Blood 102 : 223 228.
36. Xu C, Li ZS, Du YQ, Tu ZX, Gong YF, Jin J, Wu HY Xu GM (2005) Construction of a recombinant attenuated Salmonella typhimurium DNA vaccine carrying Helicobacter pylori hpaA. World J Gastroentero 11 : 114 117. (Pubitemid 40090147)
37. Zendehdel N, Nasseri-Moghaddam S, Malekzadeh R, Massarrat S, Sotoudeh M Siavoshi F (2005) Helicobacter pylori reinfection rate 3 years after successful eradication. J Gastroen Hepatol 20 : 401 404.